当前位置:首页 - 行情中心 - 太龙药业(600222) - 财务分析 - 现金流量表

太龙药业

(600222)

  

流通市值:37.07亿  总市值:37.07亿
流通股本:5.74亿   总股本:5.74亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金823,784,786.09414,804,628.031,948,869,046.911,420,164,228.05
  收到的税费返还--1,579,837.62-
  收到其他与经营活动有关的现金5,417,805.342,430,749.1319,102,724.364,126,255.71
  经营活动现金流入小计829,202,591.43417,235,377.161,969,551,608.891,424,290,483.76
  购买商品、接受劳务支付的现金696,218,549.63262,741,184.621,379,341,573.311,044,385,322.31
  支付给职工以及为职工支付的现金158,727,411.3583,831,382.91344,820,358.14264,242,591.37
  支付的各项税费32,850,227.1120,398,994.9260,608,121.0945,669,396.54
  支付其他与经营活动有关的现金53,088,037.4439,313,365.14224,367,275.11166,707,981.21
  经营活动现金流出小计940,884,225.53406,284,927.592,009,137,327.651,521,005,291.43
  经营活动产生的现金流量净额-111,681,634.110,950,449.57-39,585,718.76-96,714,807.67
二、投资活动产生的现金流量:
  收回投资收到的现金122,019,785.6683,954,415.01529,307,835.29499,421,614.55
  取得投资收益收到的现金22,992,730.6418,070,053.552,630,103.962,435,565.17
  处置固定资产、无形资产和其他长期资产收回的现金净额60,42683,300167,181155,181
  收到的其他与投资活动有关的现金0-3,249,654.213,249,654.21
  投资活动现金流入小计145,072,942.3102,107,768.56535,354,774.46505,262,014.93
  购建固定资产、无形资产和其他长期资产支付的现金6,611,350.794,412,158.4937,231,519.199,440,372.88
  投资支付的现金47,750,0008,250,000479,872,300399,862,300
  投资活动现金流出小计54,361,350.7912,662,158.49517,103,819.19409,302,672.88
  投资活动产生的现金流量净额90,711,591.5189,445,610.0718,250,955.2795,959,342.05
三、筹资活动产生的现金流量:
  取得借款收到的现金702,635,766.27294,709,780.95833,494,585.88528,299,007.07
  收到其他与筹资活动有关的现金314,900,000129,900,000534,162,654.09342,500,000
  筹资活动现金流入小计1,017,535,766.27424,609,780.951,367,657,239.97870,799,007.07
  偿还债务支付的现金553,540,971.74242,479,797.52552,411,298.76306,695,011.44
  分配股利、利润或偿付利息支付的现金28,338,146.3615,559,948.3169,068,473.6453,507,856.27
  支付其他与筹资活动有关的现金340,096,080.1743,060,953.58755,953,313.92355,400,947.25
  筹资活动现金流出小计921,975,198.27301,100,699.411,377,433,086.32715,603,814.96
  筹资活动产生的现金流量净额95,560,568123,509,081.54-9,775,846.35155,195,192.11
五、现金及现金等价物净增加额74,590,525.41223,905,141.18-31,110,609.84154,439,726.49
  加:期初现金及现金等价物余额143,892,905.85143,892,905.85175,003,515.69175,003,515.69
  期末现金及现金等价物余额218,483,431.26367,798,047.03143,892,905.85329,443,242.18
补充资料:
  净利润22,601,677.95-53,495,468.69-
  资产减值准备-9,807,663.33-7,323,009.67-
  固定资产和投资性房地产折旧23,959,380.24-46,204,926.79-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧23,959,380.24-46,204,926.79-
  无形资产摊销2,905,223.24-5,584,475.72-
  长期待摊费用摊销4,469,147.1-8,377,537.62-
  处置固定资产、无形资产和其他长期资产的损失0--129,923.84-
  固定资产报废损失73,320.16--2,544.69-
  公允价值变动损失-1,451,657.5--7,937,549.17-
  财务费用27,156,765.34-57,515,697.14-
  投资损失596,645.68--2,736,772.52-
  递延所得税-146,132.52--20,075,862.08-
  其中:递延所得税资产减少-2,388,444.72--18,966,120.63-
    递延所得税负债增加2,242,312.2--1,109,741.45-
  存货的减少-108,237,768.17-91,063,826.47-
  经营性应收项目的减少-2,248,894.6--91,315,475.51-
  经营性应付项目的增加-81,857,859.17--196,555,964.71-
  现金的期末余额218,483,431.26-143,892,905.85-
  减:现金的期初余额143,892,905.85-175,003,515.69-
  现金及现金等价物的净增加额74,590,525.41--31,110,609.84-
公告日期2025-08-272025-04-302025-04-092024-10-25
审计意见(境内)标准无保留意见
TOP↑